Search Within

Teresa A Gilewski

Formats
  1. Journal Article (51)
  2. Meeting Abstract (32)
  3. Book Section (10)
  4. Conference Paper (4)
Groups
  1. Behavioral Sciences Service (97)
  2. Breast Medicine Service (97)
  3. Department of Medicine (97)
  4. Psychiatry and Behavioral Sciences, Department of (97)
  5. Solid Tumor Oncology Division (97)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (82)

More Groups

People
  1. Larry Norton (77)
  2. Clifford Hudis (57)
  3. Andrew Seidman (38)
  4. Mary Ellen Moynahan (26)
  5. Violante Currie (25)
  6. Gabriella D'Andrea-Carlino (24)

More People

Years
  1. 2020 (1)
  2. 2018 (1)
  3. 2015 (5)
  4. 2014 (2)
  5. 2013 (2)
  6. 2012 (5)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Cancer Research (9)
  3. Breast Cancer Research and Treatment (8)
  4. Clinical Cancer Research (6)
  5. Clinical Breast Cancer (4)
  6. Expert Consultations in Breast Cancer: Critical Pathways and Clinical Decision Making (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (18)
  3. Elsevier Inc. (9)
  4. Springer (9)
  5. American Medical Association (4)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (97)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cytokinetics
    Book Section

    Norton, L.; Gilewski, T. A.
    In Hong, W. K.; Bast, R. C. Jr; Hait, W. N.; Kufe, D. W.; Pollock, R. E.; Weichselbaum, R. R.; Holland, J. F.; Frei, E. 3rd (Eds.) Holland-Frei Cancer Medicine. 8th ed (2010)

    Fulltext@MSK | Save
  • Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study
    Meeting Abstract

    Fornier, M. N.; Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C. T.; Dickler, M. N.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The development and implementation of an institution-based communication skills training program for oncologists
    Meeting Abstract

    Bialer, P. A.; Gilewski, T.; Kissane, D.; Levin, T.; Dickler, M. N.; Park, B. J.; Bylund, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I-II trial of dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Lake, D.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • STRIDE: Phase III study of therapeutic cancer vaccine L-BLP25 with hormonal treatment as first-line therapy for women with hormone receptor-positive, inoperable, locally advanced, recurrent, or metastatic breast cancer
    Meeting Abstract

    Eiermann, W.; Miles, D.; Gilewski, T.; Trudeau, M.; Xu, B.; Barrios, C.; Pendergrass, K.; Eggleton, S. P.; Kashala, O.; Shulman, L.
    EJC Supplements (2010)

    Fulltext@MSK | Save
  • Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer
    Journal Article

    Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save